OSLO, Norway, Feb. 27, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that its marketing authorization application (MAA) for Cevira® (APL-1702) for the treatment of high-grade...
Hence then, the article about photocure partner asieris announces that ema has accepted marketing authorization application for cevira in europe was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Photocure partner Asieris announces that EMA has accepted Marketing Authorization Application for CEVIRA in Europe )
Also on site :
- Samsung Taps SUGA for New Galaxy Buds4 Pro Earbuds Announcement: Shop It Here
- Walmart Has 'Very Comfortable' Kitten Heel Booties on Sale for Just $50 in 3 'Stylish' Colors
- 'Survivor' Fan Favorite Shares Health Update After Season 50-Ending Injury